KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Cash from Operations (2018 - 2025)

Historic Cash from Operations for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $912.7 million.

  • BioNTech SE's Cash from Operations rose 23007.6% to $912.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$237.8 million, marking a year-over-year decrease of 11466.4%. This contributed to the annual value of $221.9 million for FY2024, which is 9615.96% down from last year.
  • According to the latest figures from Q3 2025, BioNTech SE's Cash from Operations is $912.7 million, which was up 23007.6% from $165.8 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Cash from Operations ranged from a high of $4.8 billion in Q3 2022 and a low of -$821.2 million during Q1 2025
  • Moreover, its 5-year median value for Cash from Operations was $846.0 million (2022), whereas its average is $1.2 billion.
  • Per our database at Business Quant, BioNTech SE's Cash from Operations skyrocketed by 121056620371.66% in 2022 and then tumbled by 17945.65% in 2024.
  • Quarter analysis of 5 years shows BioNTech SE's Cash from Operations stood at $228.2 million in 2021, then skyrocketed by 270.69% to $846.0 million in 2022, then increased by 8.22% to $915.5 million in 2023, then crashed by 154.08% to -$495.1 million in 2024, then surged by 284.35% to $912.7 million in 2025.
  • Its last three reported values are $912.7 million in Q3 2025, $165.8 million for Q2 2025, and -$821.2 million during Q1 2025.